Vikaash Kumar
Impact in
- Oncology top 10%
- Cancer survivorship and care
- PARP inhibition in cancer therapy
-
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Advanced Breast Cancer Therapies
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 14
- HER2/EGFR in Cancer Research 4
- Cancer Treatment and Pharmacology 3
- PARP inhibition in cancer therapy 2
- Cancer Immunotherapy and Biomarkers 2
-
- Advanced Breast Cancer Therapies 6
- Co-authors
- Mark J. Haykowsky (2 shared papers)Neil D. Eves (2 shared papers)Kerry S. Courneya (2 shared papers)Tony Reiman (2 shared papers)Carolyn J. Peddle‐McIntyre (2 shared papers)Lee W. Jones (1 shared paper)Christopher Gray (1 shared paper)John R. Mackey (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer (1 paper)Radiotherapy and Oncology (1 paper)Scientific Reports (1 paper)JAMA Oncology (1 paper)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Vikaash Kumar
18 papers receiving 573 citations
Peers
Comparison fields: 5 of 71
- Oncology 309
- Pulmonary and Respiratory Medicine 264
- Cancer Research 83
- Geriatrics and Gerontology 21
- Cardiology and Cardiovascular Medicine 85
Countries citing papers authored by Vikaash Kumar
This map shows the geographic impact of Vikaash Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikaash Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikaash Kumar more than expected).
Fields of papers citing papers by Vikaash Kumar
This network shows the impact of papers produced by Vikaash Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikaash Kumar. The network helps show where Vikaash Kumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Vikaash Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 252 | |
| 2 | 2018 | 99 | |
| 3 | 2020 | 51 | |
| 4 | 2009 | 51 | |
| 5 | 2015 | 41 | |
| 6 | 2017 | 32 | |
| 7 | 2011 | 21 | |
| 8 | 2024 | 19 | |
| 9 | 2013 | 6 | |
| 10 | 2025 | 3 | |
| 11 | 2024 | 2 | |
| 12 | 2025 | 2 | |
| 13 | 2024 | 1 | |
| 14 | 2025 | 1 | |
| 15 | 2023 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2013 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Vikaash Kumar
Vikaash Kumar is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research and Surgery, having authored 22 papers that have together received 585 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (6 papers), HER2/EGFR in Cancer Research (4 papers), Cancer Treatment and Pharmacology (3 papers), Breast Cancer Treatment Studies (3 papers), Bladder and Urothelial Cancer Treatments (2 papers), PARP inhibition in cancer therapy (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (309 citations), Pulmonary and Respiratory Medicine (264 citations), Cancer Research (83 citations), Geriatrics and Gerontology (21 citations) and Cardiology and Cardiovascular Medicine (85 citations). Vikaash Kumar has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Mark J. Haykowsky, Neil D. Eves, Kerry S. Courneya, Tony Reiman, Carolyn J. Peddle‐McIntyre, Lee W. Jones, Christopher Gray, John R. Mackey, Jagdeep S. Walia and Anil A. Joy. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Radiotherapy and Oncology, Scientific Reports and JAMA Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.